Of interest, overexpression of Transforming growth factor alfa (TGF-α), a specific EGFR ligand, induced EGFR–MET interaction, with subsequent MET phosphorylation and activation of downstream effectors in EGFR-independent manner causing cetuximab resistance in colorectal cancer cells [59]. The gene discussed is MET; the disease is colorectal cancer.